SPL Medical | SPL medical has applied for Market Authorization of its innovative MRI contrast in major EU countries. https://splmed.com/english Accurate Cancer Diagnostics Thu, 19 Mar 2026 08:41:04 +0000 en-GB hourly 1 SPL medical has applied for Market Authorization of its innovative MRI contrast in major EU countries. https://splmed.com/english/spl-medical-has-applied-for-market-authorization-of-its-innovative-mri-contrast-in-major-eu-countries/ Thu, 19 Mar 2026 08:36:35 +0000 https://splmed.com/?p=6320 Ferumoxtran, the iron-based investigational MRI contrast agent of SPL Medical B.V., meets primary endpoints in pivotal Phase III study. https://splmed.com/english/ferumoxtran-the-iron-based-investigational-mri-contrast-agent-of-spl-medical-b-v-meets-primary-endpoints-in-pivotal-phase-iii-study/ Tue, 25 Feb 2025 13:48:54 +0000 https://splmed.com/?p=6282 SPL Medical is welcoming a powerful open-access publication in European Radiology highlighting the useability of Ferrotran® (Ferumoxtran) for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma. https://splmed.com/english/spl-medical-is-welcoming-a-powerful-open-access-publication-in-european-radiology-highlighting-the-useability-of-ferrotran-ferumoxtran-for-pre-operative-metastatic-lymph-node-detection-in-panc/ Mon, 08 Jul 2024 10:44:55 +0000 https://splmed.com/?p=6264 SPL Medical has entered into an Agreement with Sanochemia Pharmazeutika GmbH for supply and worldwide distribution of Ferrotran® (Ferumoxtran) for detection of Lymph node metastases by Magnetic Resonance Imaging (MRI). https://splmed.com/english/spl-medical-has-entered-into-an-agreement-with-sanochemia-pharmazeutika-gmbh/ Mon, 11 Mar 2024 16:06:31 +0000 https://splmed.com/?p=6245 SPL Medical has entered into an Agreement with NanoEcho for supply and application of Ferrotran® (Ferumoxtran) for Ultra- sound detection of Lymph node metastases. https://splmed.com/english/spl-medical-has-entered-into-an-agreement-with-nanoecho/ Wed, 28 Feb 2024 16:04:38 +0000 https://splmed.com/?p=6243 bender gruppe startet ein KI-Projekt https://splmed.com/english/bender-gruppe-startet-ein-ki-projekt/ Wed, 08 Nov 2023 09:23:07 +0000 https://splmed.com/?p=6152 SPL Medical announces achievement of next major clinical development milestone for its breakthrough platform product Ferrotran®: Now >75% patients included in Phase III trial https://splmed.com/english/spl-medical-announces-achievement-of-next-major-clinical-development-milestone-for-its-breakthrough-platform-product-ferrotran-now-75-patients-included-in-phase-iii-trial/ Thu, 03 Aug 2023 14:06:23 +0000 https://splmed.com/?p=6132 SPL Medical – Next major clinical development milestone https://splmed.com/english/spl-medical-next-major-clinical-development-milestone/ Wed, 04 Jan 2023 12:45:50 +0000 https://splmed.com/?p=5905 SPL Medical announces achievement of major Phase III clinical development milestone https://splmed.com/english/spl-medical-announces-achievement-of-major-phase-iii-clinical-development-milestone/ Wed, 14 Dec 2022 16:59:14 +0000 https://splmed.com/?p=5929 New publication in European Urology Focus on the applicability of Ferrotran® (Ferumoxtran) https://splmed.com/english/neue-publikation-in-european-urology-focus-zur-einsetzbarkeit-von-ferrotran-ferumoxtran/ Tue, 01 Nov 2022 21:53:26 +0000 https://splmed.com/?p=5946